Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience
Access Microbiology · 01.11.2026 · 8 (11)
DOI: 10.1099/acmi.0.001068.v4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Access Microbiology, erschienen am 01.11.2026. Verfasst von Lea R Goren und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Minnesota Medical School, Minneapolis, USA. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, University of Minnesota Foundation.
Abstract (Originalsprache)
Toxoplasmosis can be challenging to diagnose, particularly in immunocompromised patients with nonspecific clinical presentations. We present a retrospective, single-centre case series of eight Toxoplasma gondii infections identified by plasma metagenomic cell-free DNA (cfDNA) sequencing in allogeneic haematopoietic stem cell transplant recipients. Nested within a larger cohort evaluating cfDNA utilization, this case series highlights a positive clinical impact of cfDNA testing in 5 out of 8 (62.5%) patients, including earlier diagnosis and changes in clinical management. These findings illustrate the potential utility of plasma cfDNA sequencing as a complement to conventional diagnostics across diverse clinical presentations of toxoplasmosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Minnesota Medical School, Minneapolis, USA.
- Division of Pediatric Infectious Diseases, University of Minnesota Medical School, Minneapolis, USA.
- Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, USA.
- Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, USA.
- Division of Stem Cell Transplantation and Children's Research Center and Pediatric Hematology and Oncology University Children's Hospital Zurich, University of Zürich, Zürich, Switzerland.
- Division of Pediatric Hematology and Oncology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland.
ORCID-Profile: Alice C Lehman, Beth Kristine Thielen
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- University of Minnesota Foundation
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Centers for Disease Control and Prevention
- National Center for Advancing Translational Sciences
Zitieren
APA
Goren, L. R., Lehman, A. C., Drozdov, D., & Thielen, B. K. (2026). Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience. Access Microbiology, 8(11). https://doi.org/10.1099/acmi.0.001068.v4
Vancouver
Goren LR, Lehman AC, Drozdov D, Thielen BK. Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience. Access Microbiology. 2026;8(11). doi:10.1099/acmi.0.001068.v4
BibTeX
@article{Goren2026,
author = {Goren, Lea R and Lehman, Alice C and Drozdov, Daniel and Thielen, Beth Kristine},
title = {Plasma metagenomic cell-free DNA sequencing identifies clinically unsuspected cases of Toxoplasma gondii infection in immunocompromised patients: a single-centre experience},
journal = {Access Microbiology},
year = {2026},
volume = {8},
number = {11},
doi = {10.1099/acmi.0.001068.v4}
}
EUVIMED